Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just need the results to be decisive enough. 121 can be very stat significant if the results are good enough.
Go IPIX!
They all do large phase 3's. It's just a question of if the results are good enough for EUA which allows revenue generation and more lucrative partnership opportunities.
If we have good results we'll be doing a phase 3. It's just a question of whether we make billions while doing so at the same time.
Go IPIX!
We just have to hope Brilacidin results are great and the FDA and other nations have the foresight to immediately authorize it for use. We need to get manufacturing scaled out immediately.
Go IPIX!
Please correct me then.
When between 2012 and Sept 2018 was the stock price below $0.30?
Thanks.
Go IPIX!
Forgive me. Allow me to correct. Every share purchased prior to September 2018. The last quarter of 2018 brought us down to the levels we have been at for nearly three years now. I didn't mean to leave out the first nine months of 2018 in my range.
Go IPIX!
Every share purchased from 2011 to 2018 is under water significantly. Im glad you showed up a couple years ago and are in the green. Good for you.
Hopefully this changes soon with COVID results.
Go IPIX!
Traders will trade but you think people who bought in 2012 were looking to sell in 2014 on the cusp of Brilacidin phase 3, partnership, and NASDAQ uplist with Kevetrin curing stage 4 spleen lesions?
Come on now.
Go IPIX!
I didn't read it that way. I saw it as a sign of confidence.
The debt he was owed would have taken precedence over shareholders in a bankruptcy. He traded the security of that $100K debt note in exchange for shares which are completely unsecured in a company that was heading to $0.00. It hit all time lows around this time.
At the time I was pleased by this though the amount was small.
Now, the mechanism for allowing that transaction remained a mystery to me. I'm not qualified to speculate on how it worked and if it was kosher. The end result was Leo traded secured debt in exchange for shares.
A drop in the bucket of what his salary has pulled and his overall share count but at least there is a hint of water there.
Go IPIX!
Youre correct about the gains side of the equation.
On the loss side he loses relatively little. His lost potential gains are not the same as our lost capital.
Go IPIX!
I believe he retired $100K worth of debt owed to him by the company in exchange for stock 2-3 years ago. I'll consider that a purchase.
Peanuts compared to his total awarded holdings and outsized salary (for the wealth destruction he has yielded share holders).
All hope lies in the Hail Mary trial results. Let some one catch the pass.
Go IPIX!
Leo certainly has more to gain than most of us.
He doesnt have much to lose though. If the COVID gamble fails we have $10M in the bank which will allow him to continue to draw a $400K salary for many years to come. The vast majority of his shares were awarded rather than purchased. So he has very little skin in the game.
The rest of us on the other hand....well...lets just hope COVID results are good.
Go IPIX!
Ask him about October. It's going to be a glorious month for IPIXers.
Go IPIX!
Why, Brilacidin, of course.
Go IPIX!
Yeah. I think we're watching ourselves miss our second window in slow motion here. As with the UK these Delta waves top out within five weeks. We'll probably be getting results as the Delta hype wave reaches another trough though we could be saved by a resurgence due to back-to-school.
This is an absolute tragedy to go through two full waves with the cure locked away in research labs while big pharma just eats up taxpayer and insurance money.
Go IPIX!
Nope. I said we'll definitely get data by the end of October with a 65% chance of getting it in September.
Don't make things up.
Go IPIX!
They did. Sunspotter left that part out.
30/30 placebo and 29/29 Brilacidin had AEs.
Go iPIX!
Let's see where it ends up. I was met with boos and hisses when I suggested August for data back when the trial started in February. Those people said it would take a week to fill the trial.
Trial protocol was completed 7/30. Late Sept to Early Oct is the most likely time frame for results to be delivered - two months after protocol completion.
Same as CYDY.
Same as previous B trials.
What does that offend? Does it change the outcome?
Go IPIX!
It's the constipation that gets people man. Fortunately, as AEs go, Brilacidin-OM had a lower incidence of constipation compared with the placebo.
So we have that going for us at least. As full of it as we may be, we never get stopped up.
Go IPIX!
Couple months would be before the end of October. I think we'll have the data before November.
65% chance in September.
Go IPIX!
Ivermectin is no less dubious a treatment than Remdesivir when administered by a doctor.
The key part of that statement is "administered by a doctor".
The people running out to Tractor Supply to get the livestock paste are getting imprecise dosages with loads of toxic inactive ingredients.
It would be nice to have a clear cut treatment that definitely works. Hopefully Brilacidin demonstrates this over the next couple months.
Go IPIX!
As we learned from the Prurisol phase 2b results, they will be handled in whatever manner is most advantageous to the company.
Go IPIX!
Its hard to tell who is working for the short MM. I've stated we're due to go up 5-10x on results day and that firmly plants me in the pockets of the short hedge funds.
Very very confusing situation.
Go Ayepicks!
There really is nothing for Brilacidin to attack. By vaccine nanoparticles I assume you mean one of the following:
mRNA is highly unstable (required very cold temps for storage) and degrades to nothing in a few days after injection.
Spike protein is hunted by the immune system and is generally gone completely within a month.
After two months the only difference between vac and unvax is that vax has a faster antibody and T-cell response to COVID Spike protein.
If you're talking about the tracking nanites they are injecting...no Brilacidin wont kill those as they are made of advanced alloys which are immune to defensins.
Go IPIX!
https://www.yahoo.com/lifestyle/theravance-tbph-suffers-2nd-study-131401052.html
Theravance COVID drug fails two months ago. Their UC drug fails today.
Janssen (now J&J) paid $100M upfront and $1B in payments + royalties for that UC drug in 2018.
I wonder what drug might be a great COVID AND UC candidate? More importantly I'm wondering what J&J is looking to do with all that vaccine money. Possibly replenish the Theravance gap in their pipeline?
Pay day is coming soon...it's all a question of when and how much?
Go IPIX!
That and the SEC might actually take action if someone with a large number of IPIX shares accidentally lit the fuse with a fake PR.
Go IPIX!
Thank you.
Just around the corner...
of this 9 year hallway.
I didn't know you could measure a hallway in years.
But IPIX manages to find a way.
Go IPIX!
What are you yammering on about? I doubt the database is locked yet. Leo will get us good results as soon as he is able. There was no reason to expect them today.
Go IPIX!
Why are you expecting news today? It will be a couple weeks.
Go IPIX!
If they cover and go long, or at least just cover then they would be out of the way, no?
I'd rather have the alleged villains on our side, or at least indifferent, as we head into results.
Go IPIX!
Correct. I'm not aware of anyone who was short in 2015 that did not cover by the end of 2019. The idea that one would hold out for the remaining nickel/dime to avoid paying taxes is silly.
If someone shorts something from $3 to $0.10. They'll gladly pay tax on their gains.
If one shorted one share for $3 worth of IPIX, covered at $0.10. They made $2.90. Pay 30% tax on that and you're left with about $5 including your principal. Now go long with that $5....you get 50 shares after taxes.
Now say you shorted 10,000 shares in 2015. With that same strategy you have 500,000 shares of IPIX with the same amount of capital.
Go IPIX!
I looked but I didn't say anything that trumped "29/30 mod-severe COVID patients going home in 5 days or less".
Right.
Maybe like this drug we'll have clinical data to back up that opinion shortly.
The bar is rising fast, particularly when it comes to BP paying up for the privilege.
Go IPIX!
Well, I don't. Which is why I discounted the Kintor Pharma (Chinese Communist Party).
Hydro and bleach don't post those kind of numbers. Israeli biotech isn't well-known for clinical trial fraud either.
The alleged numbers are impressive.
The double-blind, placebo controlled 155 person trial is posted but not recruiting yet
https://clinicaltrials.gov/ct2/show/NCT04969172
Go IPIX!
What's everyone's opinion on this five-day aerosol treatment out of Israel?
29/30 mod-severe COVID patients out in five days or less.
https://healthcaremarketexperts.com/en/news/i...-research/
Looks like results we're dreaming Brilacidin gets. What am I missing?
Go IPIX!